Real-time enrollment status for this medulloblastoma clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 6:28 PM UTC
| NCT Number | NCT06701812 |
| Recruiting Status | Recruiting |
| Condition | Medulloblastoma |
| Phase | PHASE2 |
| Target Enrollment | 23 participants |
| Active Locations | 15 sites in the US |
| Sponsor | H. Lee Moffitt Cancer Center and Research Institute |
| Last Updated on CT.gov | July 7, 2026 (1 week ago) |
As of July 17, 2026: Clinical trial NCT06701812 is currently recruiting participants. This phase2 study for medulloblastoma is actively seeking new participants at 15 locations across the United States. The study is sponsored by H. Lee Moffitt Cancer Center and Research Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06701812 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06701812 was last updated 1 week ago (July 7, 2026). HelloStudys verifies this status automatically.